Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia

Parkinsonism and Related Disorders

Volumn 15, Issue 2, 2009, Pages 105-109

  Mellick, George D ^a   Siebert, Gerhard A ^a   Funayama, Manabu ^b   Buchanan, Daniel D ^c   Li, Yuanzhe ^b   Imamichi, Yoko ^b   Yoshino, Hiroyo ^b   Silburn, Peter A ^a,c   Hattori, Nobutaka ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Mutations; PARK genes; Parkinson's disease

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DJ 1 GENE; DRUG RESPONSE; EXON; FEMALE; GENE; GENE DOSAGE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARK GENE; PARKINSON DISEASE; PINK1 GENE; PRIORITY JOURNAL; PRKN GENE;

ADULT; AGE OF ONSET; AGED; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC SCREENING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; QUEENSLAND; UBIQUITIN-PROTEIN LIGASES;

EID: 58349122909     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.11.016     Document Type: Article

References (31)

1. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157 (2003) 1015-1022
2. Kobayashi T., Matsumine H., Zhang J., Imamichi Y., Mizuno Y., and Hattori N. Pseudo-autosomal dominant inheritance of PARK2: two families with parkin gene mutations. J Neurol Sci 207 (2003) 11-17
3. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., et al. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392 (1998) 605-608
4. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., et al. Parkinson disease in twins: an etiologic study. JAMA 281 (1999) 341-346
5. Piccini P., Burn D.J., Ceravolo R., Maraganore D., and Brooks D.J. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45 (1999) 577-582
6. Takahashi H., Ohama E., Suzuki S., Horikawa Y., Ishikawa A., Morita T., et al. Familial juvenile Parkinsonism: clinical and pathologic study in a family. Neurology 44 (1994) 437-441
7. Hedrich K., Marder K., Harris J., Kann M., Lynch T., Meija-Santana H., et al. Evaluation of 50 probands with early-onset Parkinson's disease for parkin mutations. Neurology 58 (2002) 1239-1246
8. Klein C., Hedrich K., Wellenbrock C., Kann M., Harris J., Marder K., et al. Frequency of parkin mutations in late-onset Parkinson's disease. Ann Neurol 54 (2003) 415-416 author reply 6-7
9. Lucking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 342 (2000) 1560-1567
10. Periquet M., Latouche M., Lohmann E., Rawal N., De Michele G., Ricard S., et al. Parkin mutations are frequent in patients with isolated early-onset Parkinsonism. Brain 126 (2003) 1271-1278
11. Khan N.L., Graham E., Critchley P., Schrag A.E., Wood N.W., Lees A.J., et al. Parkin disease: a phenotypic study of a large case series. Brain 126 (2003) 1279-1292
12. Sun M., Latourelle J.C., Wooten G.F., Lew M.F., Klein C., Shill H.A., et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol 63 (2006) 826-832
13. Hertz J.M., Ostergaard K., Juncker I., Pedersen S., Romstad A., Moller L.B., et al. Low frequency of parkin, tyrosine hydroxylase, and GTP cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease. Eur J Neurol 13 (2006) 385-390
14. Lincoln S.J., Maraganore D.M., Lesnick T.G., Bounds R., de Andrade M., Bower J.H., et al. Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord 18 (2003) 1306-1311
15. Lesage S., Lohmann E., Tison F., Durif F., Durr A., and Brice A. Rare heterozygous parkin variants in French early-onset Parkinson's disease patients and controls. J Med Genet (2007)
16. Chen R., Gosavi N.S., Langston J.W., and Chan P. Parkin mutations are rare in patients with young-onset Parkinsonism in a US population. Parkinsonism Relat Disord 9 (2003) 309-312
17. Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H., et al. Novel PINK1 mutations in early-onset Parkinsonism. Ann Neurol 56 (2004) 424-427
18. Hatano Y., Sato K., Elibol B., Yoshino H., Yamamura Y., Bonifati V., et al. PARK6-linked autosomal recessive early-onset Parkinsonism in Asian populations. Neurology 63 (2004) 1482-1485
19. Bonifati V., Rohe C.F., Breedveld G.J., Fabrizio E., De Mari M., Tassorelli C., et al. Early-onset Parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65 (2005) 87-95
20. Healy D.G., Abou-Sleiman P.M., Gibson J.M., Ross O.A., Jain S., Gandhi S., et al. PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology 63 (2004) 1486-1488
21. Rogaeva E., Johnson J., Lang A.E., Gulick C., Gwinn-Hardy K., Kawarai T., et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 61 (2004) 1898-1904
22. Abou-Sleiman P.M., Muqit M.M., McDonald N.Q., Yang Y.X., Gandhi S., Healy D.G., et al. A heterozygous effect for PINK1 mutations in Parkinson's disease?. Ann Neurol 60 (2006) 414-419
23. Zadikoff C., Rogaeva E., Djarmati A., Sato C., Salehi-Rad S., St George-Hyslop P., et al. Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients. Mov Disord 21 (2006) 875-879
24. Toft M., Myhre R., Pielsticker L., White L.R., Aasly J.O., and Farrer M.J. PINK1 mutation heterozygosity and the risk of Parkinson's disease. J Neurol Neurosurg Psychiatr 78 (2007) 82-84
25. Hedrich K., Djarmati A., Schafer N., Hering R., Wellenbrock C., Weiss P.H., et al. DJ-1 (PARK7) mutations are less frequent than parkin (PARK2) mutations in early-onset Parkinson disease. Neurology 62 (2004) 389-394
26. Funayama M., Hasegawa K., Kowa H., Saito M., Tsuji S., and Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51 (2002) 296-301
27. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 (2005) 410-412
28. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
29. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354 (2006) 424-425
30. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354 (2006) 422-423
31. Bras J.M., Guerreiro R.J., Ribeiro M.H., Januario C., Morgadinho A., Oliveira C.R., et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 20 (2005) 1653-1655